PATENT CLAIM ANALYSIS

Application Number: 15945854
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "252170"]

Abstract:
The present invention relates to the use of CFTR correctors in the treatment of genetic disorders affecting striated muscle selected from sarcoglycanopathies, Brody's disease (BD) and the recessive forms of Cathecolaminergic Polymorphic Ventricular Tachycardia (CPVT).

Claim (Index 7):
A method according to  claim 6 , wherein the genetic disorder affecting striated muscle is Brody's disease (BD).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14647773', '14910941', '14238925', '15675000', '12682428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695787756286459
- 35 USC 102 Novelty (BERT): 0.6408565189381865
- Combined Prediction Score: 0.7567065499596
- Mean Citation Score: 416.171688
- Max Citation Score: 1071.8658
- Similarity Product: 574.4121120863199

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test